by Don Gibbons | May 25, 2023
A recent Wall Street Journal article reminded me of the work of someone I came to know well while at the California Institute for Regenerative Medicine (CIRM): Jeanne Loring of the Scripps Research Institute. The article detailed a cell therapy for Parkinson’s Disease...
by Francesco Zangari | May 10, 2023
CRISPR-Cas9 is not only a revolutionary technology, it is also a topic that never ceases to intrigue. From gene editing to agriculture, the possibilities are seemingly endless. In medicine, CRISPR-Cas9 has shown promising results in curing genetic blood disorders and...
by Don Gibbons | May 4, 2023
For people like me working in the biological science sector, the annual DNA Day (every April 25th) is always a cause to raise a toast, but this year was special. It marked the 70th anniversary of the discovery of the double helix by Watson and Crick (and Franklin) and...
by Sara M. Nolte | Apr 18, 2023
One of the major limitations of using stem cell donors is the challenge of finding an adequate match, which is why I always get excited about therapies that use a patient’s own tissue. But why is the issue of a “match” such a big deal? You may have come across terms...
by Laine Bodnar | Mar 23, 2023
OpenAI’s recent release of GPT-4 has made headlines in the last week. It is the latest version of the large language model that powers its popular artificial intelligence (AI) chat bot: ChatGPT. Passing the U.S. bar exam is one of its notable accomplishments. Plus,...
by Sara M. Nolte | Jan 19, 2023
While you all know me as a writer for Signals, I actually spend most of time working clinically. When wearing my health-care provider hat as a physician assistant in orthopaedics, I’m often asked about the use of stem cell therapy for the treatment of arthritis....
Comments